Form 4 for AXGN Axogen, Inc.
Accepted 2025-11-07 00:00:00 ET · period of report 2025-11-05 · accession 0000805928-25-000134 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-11-07 | 2025-11-05+ | AXGN | Burke William P. Mr. | Dir | S - Sale+OE | $24.04 | -16.8K | 100 | -99% | -$403.3K |
| DM | 2025-11-07 | 2025-11-05+ | AXGN | Burke William P. Mr. | Dir | M - OptEx | $8.14 | +16.8K | 11.5K | New | +$136.6K |
| DM | 2025-11-07 | 2025-11-05+ | AXGN | Burke William P. Mr. | Dir | M - OptEx | $0.00 | -16.8K | 22.8K | -42% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-06 | S | D | 5,347 | $24.01 | 100 | D | — | — | (F2) The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.06 per share. The Reporting Person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2025-11-06 | M | A | 5,347 | $8.14 | 5,447 | D | — | — | |
| 3 | Common | Common Stock | 2025-11-05 | M | A | 11,431 | $8.14 | 11,531 | D | — | — | |
| 4 | Common | Common Stock | 2025-11-05 | S | D | 11,431 | $24.05 | 100 | D | — | — | (F1) The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.25 per share. The Reporting Person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 5 | Derivative | Stock Option (right to purchase) | 2025-11-05 | M | D | 11,431 | $0.00 | 28,165 | D | $8.14 · — to 2032-07-11 | 11,431 Common Stock | (F3) This grant vested in three equal annual installments on the annual anniversary of the grant date, July 11, 2022. |
| 6 | Derivative | Stock Option (right to purchase) | 2025-11-06 | M | D | 5,347 | $0.00 | 22,818 | D | $8.14 · — to 2032-07-11 | 5,347 Common Stock | (F3) This grant vested in three equal annual installments on the annual anniversary of the grant date, July 11, 2022. |